Corvus Pharmaceuticals
Dr. Mahabhashyam joined Corvus in 2019 and has served as its Vice President of Clinical Development since 2020. He was Vice President Drug Safety at Infinity Pharmaceuticals from 2016 to 2019. Prior to Infinity, he was Senior Medical Director at Alexion from 2012 to 2015. Dr. Mahabhashyam earned his medical degree from Bangalore Medical College and his MPH in epidemiology from University of North Texas Health Science Center.
This person is not in any offices
Corvus Pharmaceuticals
2 followers
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.